Titre : Protéines de liaison au TGF-bêta latent

Protéines de liaison au TGF-bêta latent : Questions médicales fréquentes

Termes MeSH sélectionnés :

Attention Deficit Disorder with Hyperactivity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines de liaison au TGF-bêta latent : Questions médicales les plus fréquentes", "headline": "Protéines de liaison au TGF-bêta latent : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines de liaison au TGF-bêta latent : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-18", "dateModified": "2025-04-14", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines de liaison au TGF-bêta latent" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines de la matrice extracellulaire", "url": "https://questionsmedicales.fr/mesh/D016326", "about": { "@type": "MedicalCondition", "name": "Protéines de la matrice extracellulaire", "code": { "@type": "MedicalCode", "code": "D016326", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.860.300" } } }, "about": { "@type": "MedicalCondition", "name": "Protéines de liaison au TGF-bêta latent", "alternateName": "Latent TGF-beta Binding Proteins", "code": { "@type": "MedicalCode", "code": "D053779", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Nalani Sachan", "url": "https://questionsmedicales.fr/author/Nalani%20Sachan", "affiliation": { "@type": "Organization", "name": "Department of Cell Biology, NYU Grossman School of Medicine, New York, New York, USA." } }, { "@type": "Person", "name": "Hui Liu", "url": "https://questionsmedicales.fr/author/Hui%20Liu", "affiliation": { "@type": "Organization", "name": "Department of Experimental Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an, 710038, Shanxi, China." } }, { "@type": "Person", "name": "Daniel Rifkin", "url": "https://questionsmedicales.fr/author/Daniel%20Rifkin", "affiliation": { "@type": "Organization", "name": "Department of Cell Biology, NYU Grossman School of Medicine, New York, New York, USA." } }, { "@type": "Person", "name": "Karan Singh", "url": "https://questionsmedicales.fr/author/Karan%20Singh", "affiliation": { "@type": "Organization", "name": "Department of Cell Biology, NYU Grossman School of Medicine, New York, New York, USA." } }, { "@type": "Person", "name": "Hong-Lian Wang", "url": "https://questionsmedicales.fr/author/Hong-Lian%20Wang", "affiliation": { "@type": "Organization", "name": "Research Center for Integrative Medicine, The Affiliated Traditional Medicine Hospital of Southwest Medical University, Luzhou 646000, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Attachment in adolescents with attention deficit hyperactivity disorder and oppositional defiant disorder.", "datePublished": "2022-06-30", "url": "https://questionsmedicales.fr/article/36342984", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.12740/PP/OnlineFirst/130366" } }, { "@type": "ScholarlyArticle", "name": "Prevalence of Personality Disorders in Adults With Attention Deficit Hyperactivity Disorder (ADHD).", "datePublished": "2023-03-16", "url": "https://questionsmedicales.fr/article/36927130", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/10870547231161531" } }, { "@type": "ScholarlyArticle", "name": "Pragmatic Deficits in Attention Deficit/Hyperactivity Disorder: Systematic Review and Meta-Analysis.", "datePublished": "2023-03-28", "url": "https://questionsmedicales.fr/article/36975307", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/10870547231161534" } }, { "@type": "ScholarlyArticle", "name": "Oculomotor deficits in attention deficit hyperactivity disorder: a systematic review and meta-analysis.", "datePublished": "2022-10-24", "url": "https://questionsmedicales.fr/article/36280758", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41433-022-02284-z" } }, { "@type": "ScholarlyArticle", "name": "Characterizing the metabolomic signature of attention-deficit hyperactivity disorder in twins.", "datePublished": "2023-04-25", "url": "https://questionsmedicales.fr/article/37100381", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neuropharm.2023.109562" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Scléroprotéines", "item": "https://questionsmedicales.fr/mesh/D012596" }, { "@type": "ListItem", "position": 5, "name": "Protéines de la matrice extracellulaire", "item": "https://questionsmedicales.fr/mesh/D016326" }, { "@type": "ListItem", "position": 6, "name": "Protéines de liaison au TGF-bêta latent", "item": "https://questionsmedicales.fr/mesh/D053779" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines de liaison au TGF-bêta latent - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines de liaison au TGF-bêta latent", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines de liaison au TGF-bêta latent", "description": "Comment diagnostiquer une anomalie des protéines de liaison au TGF-bêta ?\nQuels tests sont utilisés pour évaluer le TGF-bêta ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème avec le TGF-bêta ?\nY a-t-il des marqueurs spécifiques pour ces protéines ?", "url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines de liaison au TGF-bêta latent", "description": "Quels symptômes sont associés à une dysfonction du TGF-bêta ?\nLa douleur est-elle un symptôme courant ?\nPeut-on observer des anomalies cutanées ?\nLes troubles respiratoires sont-ils liés au TGF-bêta ?\nY a-t-il des signes d'inflammation systémique ?", "url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines de liaison au TGF-bêta latent", "description": "Comment prévenir les troubles liés au TGF-bêta ?\nY a-t-il des mesures spécifiques à prendre ?\nLes vaccinations sont-elles importantes ?\nL'éducation des patients est-elle cruciale ?\nLe suivi médical régulier est-il recommandé ?", "url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines de liaison au TGF-bêta latent", "description": "Quels traitements sont disponibles pour les troubles liés au TGF-bêta ?\nLa thérapie génique est-elle une option ?\nLes corticostéroïdes sont-ils utilisés ?\nY a-t-il des traitements expérimentaux ?\nLes changements de mode de vie peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines de liaison au TGF-bêta latent", "description": "Quelles complications peuvent survenir ?\nLes complications cardiovasculaires sont-elles possibles ?\nY a-t-il un risque accru de cancer ?\nLes troubles neurologiques peuvent-ils être liés ?\nComment gérer les complications ?", "url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines de liaison au TGF-bêta latent", "description": "Quels sont les principaux facteurs de risque ?\nLe vieillissement est-il un facteur de risque ?\nL'obésité influence-t-elle le risque ?\nLe stress a-t-il un impact ?\nLes infections peuvent-elles être un facteur ?", "url": "https://questionsmedicales.fr/mesh/D053779?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie des protéines de liaison au TGF-bêta ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins et des analyses génétiques pour détecter des mutations." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer le TGF-bêta ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des dosages immunologiques et des tests ELISA sont couramment utilisés pour mesurer le TGF-bêta." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des biopsies peuvent être effectuées pour évaluer les tissus affectés et la présence de TGF-bêta." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème avec le TGF-bêta ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme l'inflammation chronique ou des troubles de cicatrisation peuvent indiquer un problème." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs spécifiques pour ces protéines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des marqueurs comme le TGF-bêta actif peuvent être utilisés pour évaluer leur fonction." } }, { "@type": "Question", "name": "Quels symptômes sont associés à une dysfonction du TGF-bêta ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles immunitaires, des fibroses et des anomalies de cicatrisation." } }, { "@type": "Question", "name": "La douleur est-elle un symptôme courant ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs peuvent survenir en raison d'inflammation ou de fibrose tissulaire." } }, { "@type": "Question", "name": "Peut-on observer des anomalies cutanées ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies cutanées comme des cicatrices hypertrophiques peuvent se produire." } }, { "@type": "Question", "name": "Les troubles respiratoires sont-ils liés au TGF-bêta ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles respiratoires peuvent survenir en raison de fibrose pulmonaire associée." } }, { "@type": "Question", "name": "Y a-t-il des signes d'inflammation systémique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des signes comme la fièvre et la fatigue peuvent indiquer une inflammation systémique." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés au TGF-bêta ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par un mode de vie sain et la gestion des maladies inflammatoires." } }, { "@type": "Question", "name": "Y a-t-il des mesures spécifiques à prendre ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabac et l'alcool peut réduire le risque de complications liées au TGF-bêta." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent aider à prévenir les infections qui exacerbent les troubles." } }, { "@type": "Question", "name": "L'éducation des patients est-elle cruciale ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les patients sur les symptômes et les facteurs de risque est essentiel." } }, { "@type": "Question", "name": "Le suivi médical régulier est-il recommandé ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi médical régulier permet de détecter précocement les anomalies." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les troubles liés au TGF-bêta ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments anti-inflammatoires et des thérapies ciblées." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie génique est explorée pour corriger des anomalies génétiques liées au TGF-bêta." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils utilisés ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les corticostéroïdes peuvent être prescrits pour réduire l'inflammation associée." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements expérimentaux, comme les inhibiteurs de TGF-bêta, sont en cours d'évaluation." } }, { "@type": "Question", "name": "Les changements de mode de vie peuvent-ils aider ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des changements comme une alimentation saine et l'exercice peuvent améliorer les symptômes." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des fibroses, des troubles respiratoires et des maladies auto-immunes." } }, { "@type": "Question", "name": "Les complications cardiovasculaires sont-elles possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications cardiovasculaires peuvent survenir en raison d'une inflammation chronique." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de cancer ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études suggèrent un lien entre TGF-bêta et certains types de cancer." } }, { "@type": "Question", "name": "Les troubles neurologiques peuvent-ils être liés ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles neurologiques peuvent être associés à des déséquilibres du TGF-bêta." } }, { "@type": "Question", "name": "Comment gérer les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion des complications nécessite une approche multidisciplinaire et un suivi régulier." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et l'exposition à des toxines." } }, { "@type": "Question", "name": "Le vieillissement est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut augmenter le risque de dysfonction des protéines de liaison au TGF-bêta." } }, { "@type": "Question", "name": "L'obésité influence-t-elle le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité est associée à une inflammation chronique, augmentant le risque de troubles." } }, { "@type": "Question", "name": "Le stress a-t-il un impact ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut exacerber les troubles liés au TGF-bêta." } }, { "@type": "Question", "name": "Les infections peuvent-elles être un facteur ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent déclencher des réponses inflammatoires affectant le TGF-bêta." } } ] } ] }

Sources (10000 au total)

Attachment in adolescents with attention deficit hyperactivity disorder and oppositional defiant disorder.

To assess attachment styles among adolescents (13-16 years) with ADHD or ADHD and oppositional defiant disorders (ODD).... The Parents and Peers Attachment (IPPA) and the Parent Bonding Questionnaire (PBI) were used in three groups of teenagers raised in biological families: (1) ADHD/ODD group (n = 40), (2) ADHD group (n ... Parental attachment styles in the area of "Trust", "Communication" and "Alienation" (IPPA), and "Care" and "Control" (PBI) in the ADHD/ODD group differ significantly compared to the control group. Tee... The attachment style is significantly different in adolescents diagnosed with ADHD and ODD than in adolescents with only ADHD. In the ADHD/ODD group and the ADHD group, unlike in the group of adolesce...

Prevalence of Personality Disorders in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

To estimate the prevalence of PDs according to Millon's evolution-based model among adult ADHD outpatients.... Cross-sectional study of consecutive patients referred to an adult ADHD clinic. PDs were evaluated with Millon Clinical Multiaxial Inventory-III (MCMI-III).... One-hundred-eighty-one participants had valid MCMI-III, of whom147 were diagnosed with ADHD. Mean age: 32.97, SD:11.56, females: 74 (50.3%). Among the 147 participants with ADHD, 29 (19.7%) did not me... Particular personality profiles were more common with different ADHD subtypes. Given the developmental origins of PD, further research may help identify possible links with childhood difficulties....

Pragmatic Deficits in Attention Deficit/Hyperactivity Disorder: Systematic Review and Meta-Analysis.

While poorer pragmatic language skills have been found in attention-deficit/hyperactivity disorder (ADHD) populations, there has been no conclusive evidence of this. We aimed to conduct a meta-analysi... Studies were identified using the search terms ((attention deficit) OR (adhd)) AND (pragmatics), and those studies were screened and reviewed for inclusion criteria, descriptive information, and outco... A total of 14 studies (5,772 participants) met the criteria for quantitative synthesis. Meta-analysis indicated that ADHD populations exhibited significantly poorer pragmatic language skills than TD p... It is suggested that pragmatic language skills may deserve greater surveillance considering the importance of pragmatic language in socio-emotional development, daily life, and academic success....

Attention deficit and hyperactivity disorder disrupts selective mechanisms of action.

People with attention deficit and hyperactivity disorder (ADHD) present attentional and emotional deficits and show paradoxical qualities such as hyperfocus. Previous studies have reported errors, slo... Thirty French children and teenagers, 15 with ADHD and 15 neurotypical (NT), underwent a saccadic eye movement task. We conducted conventional analysis (movement duration, precision, velocity, RT) and... Saccade duration and velocity failed to differentiate the two groups, whereas amplitude was higher in ADHD than in NT participants. Saccade RT and variability were higher in ADHD than in NT participan... ADHD disrupts two mechanisms of action: it reduces the gain of the decision signal, thus explaining slowness and variability; it quickens the decision process of early responses at the origin of short... These premises and their interconnections explain previous observations and support the striatal-frontal wiring of ADHD, thus explaining ADHD complexity in its negative and positive manifestations....

Psychiatric Comorbidities and Schizophrenia in Youths With Attention-Deficit/Hyperactivity Disorder.

The association between attention-deficit/hyperactivity disorder (ADHD) and schizophrenia has received increased attention; however, evidence on the association between psychiatric comorbidities and s... To investigate the risk of being diagnosed with schizophrenia in children and adolescents with ADHD considering the presence of psychiatric comorbidity.... This was a population-based, retrospective cohort study using the Health Insurance Review and Assessment claims database from January 1, 2007, to December 31, 2019. Participants were children and adol... The presence of psychiatric comorbidity was assessed from diagnosis records within 1 year before ADHD diagnosis. Comorbidities were further categorized according to the number of comorbidities and spe... Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% CIs, examining the association between psychiatric comorbidities and the risk of being diagnosed with schizophrenia. Fu... A total of 211 705 patients with newly diagnosed ADHD were included. A total of 157 272 patients (74.3%) were male, and the age of 5 to 9 years showed the highest distribution (115 081 patients [54.4%... In this retrospective cohort study involving children and adolescents with ADHD, the presence of psychiatric comorbidity in patients with ADHD was associated with an increased risk of being diagnosed ...